Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis

<p>Abstract</p> <p>Background</p> <p>Low molecular weight (LMW) heparins are used for anticoagulation during hemodialysis (HD). Studies in animals have shown that LMW-heparins release lipoprotein lipase (LPL) as efficiently as unfractionated (UF) heparin, but are less a...

Full description

Bibliographic Details
Main Authors: Olivecrona Thomas, Olivecrona Gunilla, Lundberg Lennart DI, Grubbström Maria, Mahmood Dana, Stegmayr Bernd G
Format: Article
Language:English
Published: BMC 2010-12-01
Series:BMC Nephrology
Online Access:http://www.biomedcentral.com/1471-2369/11/33
_version_ 1818385614250180608
author Olivecrona Thomas
Olivecrona Gunilla
Lundberg Lennart DI
Grubbström Maria
Mahmood Dana
Stegmayr Bernd G
author_facet Olivecrona Thomas
Olivecrona Gunilla
Lundberg Lennart DI
Grubbström Maria
Mahmood Dana
Stegmayr Bernd G
author_sort Olivecrona Thomas
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Low molecular weight (LMW) heparins are used for anticoagulation during hemodialysis (HD). Studies in animals have shown that LMW-heparins release lipoprotein lipase (LPL) as efficiently as unfractionated (UF) heparin, but are less able to retard hepatic uptake of the lipase. This raises a concern that the LPL system may become exhausted by LMW-heparin in patients on HD. We have explored this in the setting of clinical HD.</p> <p>Methods</p> <p>Twenty patients on chronic hemodialysis were switched from a primed infusion of UF-heparin to a single bolus of tinzaparin. There were long term follow up of variables for the estimation of dialysis efficacy as well as of the LPL release during dialysis and the subsequent impact on the triglycerides.</p> <p>Results</p> <p>The LPL activity in blood was higher on tinzaparin at 40 but lower at 180 minutes during HD. These values did not change during the 6 month study period. There were significant correlations between the LPL activities in individual patients at the beginning and end of the 6 month study period and between the activities on UF-heparin and on tinzaparin, indicating that tissue LPL was not being exhausted. Triglycerides were higher during the HD-session with tinzaparin than UF-heparin. The plasma lipid/lipoprotein levels did not change during the 6 month study period, nor during a 2-year follow up after the switch from UF-heparin to tinzaparin. Urea reduction rate and Kt/V were reduced by 4 and 7% after 6 months with tinzaparin.</p> <p>Conclusion</p> <p>Our data demonstrate that repeated HD with UF-heparin or tinzaparin does not exhaust the LPL-system.</p>
first_indexed 2024-12-14T03:40:57Z
format Article
id doaj.art-518f26c4e032499b846a1524fdbbcd88
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-14T03:40:57Z
publishDate 2010-12-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-518f26c4e032499b846a1524fdbbcd882022-12-21T23:18:29ZengBMCBMC Nephrology1471-23692010-12-011113310.1186/1471-2369-11-33Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysisOlivecrona ThomasOlivecrona GunillaLundberg Lennart DIGrubbström MariaMahmood DanaStegmayr Bernd G<p>Abstract</p> <p>Background</p> <p>Low molecular weight (LMW) heparins are used for anticoagulation during hemodialysis (HD). Studies in animals have shown that LMW-heparins release lipoprotein lipase (LPL) as efficiently as unfractionated (UF) heparin, but are less able to retard hepatic uptake of the lipase. This raises a concern that the LPL system may become exhausted by LMW-heparin in patients on HD. We have explored this in the setting of clinical HD.</p> <p>Methods</p> <p>Twenty patients on chronic hemodialysis were switched from a primed infusion of UF-heparin to a single bolus of tinzaparin. There were long term follow up of variables for the estimation of dialysis efficacy as well as of the LPL release during dialysis and the subsequent impact on the triglycerides.</p> <p>Results</p> <p>The LPL activity in blood was higher on tinzaparin at 40 but lower at 180 minutes during HD. These values did not change during the 6 month study period. There were significant correlations between the LPL activities in individual patients at the beginning and end of the 6 month study period and between the activities on UF-heparin and on tinzaparin, indicating that tissue LPL was not being exhausted. Triglycerides were higher during the HD-session with tinzaparin than UF-heparin. The plasma lipid/lipoprotein levels did not change during the 6 month study period, nor during a 2-year follow up after the switch from UF-heparin to tinzaparin. Urea reduction rate and Kt/V were reduced by 4 and 7% after 6 months with tinzaparin.</p> <p>Conclusion</p> <p>Our data demonstrate that repeated HD with UF-heparin or tinzaparin does not exhaust the LPL-system.</p>http://www.biomedcentral.com/1471-2369/11/33
spellingShingle Olivecrona Thomas
Olivecrona Gunilla
Lundberg Lennart DI
Grubbström Maria
Mahmood Dana
Stegmayr Bernd G
Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
BMC Nephrology
title Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
title_full Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
title_fullStr Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
title_full_unstemmed Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
title_short Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
title_sort lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis
url http://www.biomedcentral.com/1471-2369/11/33
work_keys_str_mv AT olivecronathomas lipoproteinlipaserespondssimilarlytotinzaparinastoconventionalheparinduringhemodialysis
AT olivecronagunilla lipoproteinlipaserespondssimilarlytotinzaparinastoconventionalheparinduringhemodialysis
AT lundberglennartdi lipoproteinlipaserespondssimilarlytotinzaparinastoconventionalheparinduringhemodialysis
AT grubbstrommaria lipoproteinlipaserespondssimilarlytotinzaparinastoconventionalheparinduringhemodialysis
AT mahmooddana lipoproteinlipaserespondssimilarlytotinzaparinastoconventionalheparinduringhemodialysis
AT stegmayrberndg lipoproteinlipaserespondssimilarlytotinzaparinastoconventionalheparinduringhemodialysis